Patent classifications
C08F251/00
DEXTRIN COPOLYMER WITH STYRENE AND AN ACRYLIC ESTER, MANUFACTURING METHOD THEREOF, AND USE THEREOF FOR PAPER COATING
Disclosed is a copolymer of a dextrin and at least two hydrophobic monomers made up of styrene and at least one straight or branched acrylic C1-C4 ester. The invention also relates to the manufacturing method thereof and to the use thereof in paper coating. The copolymer has high dextrin content (>60 wt % relative to the weight of the dextrin and the hydrophobic monomers) so as to favor the biosourced aspect of the material, and provides very good hydrophobicity for the paper sheet.
DEXTRIN COPOLYMER WITH STYRENE AND AN ACRYLIC ESTER, MANUFACTURING METHOD THEREOF, AND USE THEREOF FOR PAPER COATING
Disclosed is a copolymer of a dextrin and at least two hydrophobic monomers made up of styrene and at least one straight or branched acrylic C1-C4 ester. The invention also relates to the manufacturing method thereof and to the use thereof in paper coating. The copolymer has high dextrin content (>60 wt % relative to the weight of the dextrin and the hydrophobic monomers) so as to favor the biosourced aspect of the material, and provides very good hydrophobicity for the paper sheet.
Binder Compositions and Uses Thereof
The present invention relates to new aqueous curable binder compositions comprising a carbohydrate compound, a first cross linker and a second cross linker different from the first capable of undergoing radical polymerization and possibly a free radical initiator.
Binder Compositions and Uses Thereof
The present invention relates to new aqueous curable binder compositions comprising a carbohydrate compound, a first cross linker and a second cross linker different from the first capable of undergoing radical polymerization and possibly a free radical initiator.
AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS
Described herein is a method of using aqueous polymer dispersions, which are obtainable by radical aqueous emulsion polymerization in the presence of a degraded starch as an opacifier in liquid formulations. Also described herein is a process for producing the aqueous polymer dispersions. Also described herein are liquid formulations, such as detergent formulations and liquid cosmetic preparations, which contain at least one aqueous polymer dispersion.
AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS
Described herein is a method of using aqueous polymer dispersions, which are obtainable by radical aqueous emulsion polymerization in the presence of a degraded starch as an opacifier in liquid formulations. Also described herein is a process for producing the aqueous polymer dispersions. Also described herein are liquid formulations, such as detergent formulations and liquid cosmetic preparations, which contain at least one aqueous polymer dispersion.
AQUEOUS POLYMER DISPERSIONS SUITABLE AS OPACIFIERS IN LIQUID FORMULATIONS
Described herein is a method of using aqueous polymer dispersions, which are obtainable by radical aqueous emulsion polymerization in the presence of a degraded starch as an opacifier in liquid formulations. Also described herein is a process for producing the aqueous polymer dispersions. Also described herein are liquid formulations, such as detergent formulations and liquid cosmetic preparations, which contain at least one aqueous polymer dispersion.
Injectable Therapeutic Biocompatible Co-Polymers and Methods of Making and Using Same
Biocompatible copolymers and thermo-responsive hydrogels formed from the copolymers are disclosed. The biocompatible copolymers include monomers comprising polysaccharides or derivatives thereof, therapeutic agents or derivatives thereof and thermo-responsive monomers and are cross-linked with an acrylamide-containing crosslinker. The hydrogels are used as implant materials to treat or prevent joint damage or osteoarthritis in a subject.
Injectable Therapeutic Biocompatible Co-Polymers and Methods of Making and Using Same
Biocompatible copolymers and thermo-responsive hydrogels formed from the copolymers are disclosed. The biocompatible copolymers include monomers comprising polysaccharides or derivatives thereof, therapeutic agents or derivatives thereof and thermo-responsive monomers and are cross-linked with an acrylamide-containing crosslinker. The hydrogels are used as implant materials to treat or prevent joint damage or osteoarthritis in a subject.
Injectable Therapeutic Biocompatible Co-Polymers and Methods of Making and Using Same
Biocompatible copolymers and thermo-responsive hydrogels formed from the copolymers are disclosed. The biocompatible copolymers include monomers comprising polysaccharides or derivatives thereof, therapeutic agents or derivatives thereof and thermo-responsive monomers and are cross-linked with an acrylamide-containing crosslinker. The hydrogels are used as implant materials to treat or prevent joint damage or osteoarthritis in a subject.